home / stock / ctkb / ctkb news

CTKB News and Press, Cytek Biosciences Inc.

Stock Information
Company Name: Cytek Biosciences Inc.
Stock Symbol: CTKB
Market: NASDAQ
Website: cytekbio.com
Menu
CTKB CTKB Quote CTKB Short CTKB News CTKB Articles CTKB Message Board
Get CTKB Alerts

News, Short Squeeze, Breakout and More Instantly...
CTKB - Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

FREMONT, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- One year after opening its 8,500-square-foot Singapore facility, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) is marking a major milestone in its Asia-Pacific (APAC) expansion. Serving as a strategic hub supporting cus...
CTKB - Cytek (CTKB) Q4 2025 Earnings Call Transcript

2026-02-27 09:13:02 ET Image source: The Motley Fool. Thursday, Feb. 26, 2026, at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

CTKB - Cytek Biosciences outlines $205M-$212M 2026 revenue target amid record Q4 and growth in recurring revenue

2026-02-26 20:58:30 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cytek Biosciences, Inc. (CTKB) Presents at 44th Annua...

CTKB - Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

2026-02-26 20:57:47 ET Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript
CTKB - Cytek Biosciences GAAP EPS of -$0.34 misses by $0.30, revenue of $62.1M beats by $3.3M

2026-02-26 17:24:19 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha...

CTKB - Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook 

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ®  Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025....

CTKB - Expected US Company Earnings on Thursday, February 26th, 2026

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...
CTKB - Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference

FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46 th Annual Health Care Conference in Boston, MA. Cytek management is scheduled to p...

CTKB - Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. The...

CTKB - Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-15 01:45:59 ET Cytek Biosciences, Inc. (CTKB) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 8:15 PM EST... Read the full article on Seeking Alpha For further details see: Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare C...
Next 10